S. Novello

发表论文 41 篇 · 总被引 1585 次 · h-index 19

代表论文

Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial (2024 · The Lancet · 被引 242)
Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification (2018 · Nature Biotechnology · 被引 157)
Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment: a meta-analysis. (2011 · Annals of Oncology · 被引 105)
Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016 (2018 · Annals of Oncology · 被引 83)
Randomized, phase III trial of figitumumab in combination with erlotinib versus erlotinib alone in patients with nonadenocarcinoma nonsmall-cell lung cancer. (2015 · Annals of Oncology · 被引 63)
Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab (2010 · British Journal of Cancer · 被引 54)